These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32962221)

  • 61. Lower prevalence of hlyD, papC and cnf-1 genes in ciprofloxacin-resistant uropathogenic Escherichia coli than their susceptible counterparts isolated from southern India.
    Harwalkar A; Gupta S; Rao A; Srinivasa H
    J Infect Public Health; 2014; 7(5):413-9. PubMed ID: 24861644
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Fluoroquinolone-resistant and extended-spectrum β-lactamase-producing Escherichia coli from the milk of cows with clinical mastitis in Southern Taiwan.
    Su Y; Yu CY; Tsai Y; Wang SH; Lee C; Chu C
    J Microbiol Immunol Infect; 2016 Dec; 49(6):892-901. PubMed ID: 25592882
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prevalence and Characteristics of Sequence Type 131
    Park JY; Yun KW; Choi EH; Lee HJ
    Microb Drug Resist; 2018 Dec; 24(10):1552-1558. PubMed ID: 29957128
    [No Abstract]   [Full Text] [Related]  

  • 64. Human-associated fluoroquinolone-resistant Escherichia coli clonal lineages, including ST354, isolated from canine feces and extraintestinal infections in Australia.
    Guo S; Wakeham D; Brouwers HJ; Cobbold RN; Abraham S; Mollinger JL; Johnson JR; Chapman TA; Gordon DM; Barrs VR; Trott DJ
    Microbes Infect; 2015 Apr; 17(4):266-74. PubMed ID: 25576024
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Fecal carriage rates of extended-spectrum β-lactamase-producing Escherichia coli among antibiotic naive healthy human volunteers.
    Mathai D; Kumar VA; Paul B; Sugumar M; John KR; Manoharan A; Kesavan LM
    Microb Drug Resist; 2015 Feb; 21(1):59-64. PubMed ID: 25127253
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Bacteraemia due to non-ESBL-producing Escherichia coli O25b:H4 sequence type 131: insights into risk factors, clinical features and outcomes.
    Morales-Barroso I; López-Cerero L; Molina J; Bellido M; Navarro MD; Serrano L; González-Galán V; Praena J; Pascual A; Rodríguez-Baño J
    Int J Antimicrob Agents; 2017 Apr; 49(4):498-502. PubMed ID: 28257756
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Fecal carriage of extended-spectrum β-lactamase- and AmpC- producing Escherichia coli among healthcare workers.
    Bassyouni RH; Gaber SN; Wegdan AA
    J Infect Dev Ctries; 2015 Mar; 9(3):304-8. PubMed ID: 25771469
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Detection of Escherichia coli Producing CTX-M-1-Group Extended-Spectrum β-Lactamases from Pigs in Aichi Prefecture, Japan, between 2015 and 2016.
    Norizuki C; Kawamura K; Wachino JI; Suzuki M; Nagano N; Kondo T; Arakawa Y
    Jpn J Infect Dis; 2018 Jan; 71(1):33-38. PubMed ID: 29279444
    [TBL] [Abstract][Full Text] [Related]  

  • 69. First report of the new emerging global clone ST1193 among clinical isolates of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli from Germany.
    Valenza G; Werner M; Eisenberger D; Nickel S; Lehner-Reindl V; Höller C; Bogdan C
    J Glob Antimicrob Resist; 2019 Jun; 17():305-308. PubMed ID: 30682563
    [TBL] [Abstract][Full Text] [Related]  

  • 70. High Gastrointestinal Colonization Rate with Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Hospitalized Patients: Emergence of Carbapenemase-Producing K. pneumoniae in Ethiopia.
    Desta K; Woldeamanuel Y; Azazh A; Mohammod H; Desalegn D; Shimelis D; Gulilat D; Lamisso B; Makonnen E; Worku A; Mannerqvist K; Struwe J; Aspevall O; Aklillu E
    PLoS One; 2016; 11(8):e0161685. PubMed ID: 27574974
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli isolated from the rivers and lakes in Northwest China.
    Liu H; Zhou H; Li Q; Peng Q; Zhao Q; Wang J; Liu X
    BMC Microbiol; 2018 Oct; 18(1):125. PubMed ID: 30286725
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Increase in the Rate of Gut Carriage of Fluoroquinolone-Resistant Escherichia coli despite a Reduction in Antibiotic Prescriptions.
    Tchesnokova V; Larson L; Basova I; Sledneva Y; Choudhury D; Heng J; Solyanik T; Bonilla T; Pham S; Schartz E; Madziwa L; Holden E; Weissman S; Ralston J; Sokurenko E
    Res Sq; 2023 Jan; ():. PubMed ID: 36712036
    [No Abstract]   [Full Text] [Related]  

  • 73. Pantoprazole promotes sustained intestinal carriage of multidrug-resistant Escherichia coli in amoxicillin-treated mice.
    Moaligou C; Dion M; Ishnaiwer M; Dailly É; Batard É; Javaudin F
    J Appl Microbiol; 2023 Oct; 134(10):. PubMed ID: 37766396
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Epidemiology of and risk factors associated with third-generation cephalosporin-resistant Escherichia coli carriage in children: A comparison between regions in Taiwan.
    Chiang WL; Chi H; Cheng JL; Cheng MF
    Pediatr Neonatol; 2024 Aug; ():. PubMed ID: 39313401
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Fecal Carriage of Colibactin-Encoding
    Akinduti PA; Izevbigie OO; Akinduti OA; Enwose EO; Amoo EO
    Open Forum Infect Dis; 2024 Apr; 11(4):ofae106. PubMed ID: 38560611
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Evidence that faecal carriage of resistant
    Mounsey O; Wareham K; Hammond A; Findlay J; Gould VC; Morley K; Cogan TA; Turner KME; Avison MB; Reyher KK
    One Health; 2022 Jun; 14():100370. PubMed ID: 35146110
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Correction: Effects of chronic exposure to arsenic on the fecal carriage of antibiotic-resistant Escherichia coli among people in rural Bangladesh.
    Amin MB; Talukdar PK; Asaduzzaman M; Roy S; Flatgard BM; Islam MR; Saha SR; Sharker Y; Mahmud ZH; Navab-Daneshmand T; Kile ML; Levy K; Julian TR; Islam MA
    PLoS Pathog; 2023 Sep; 19(9):e1011690. PubMed ID: 37773936
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Fecal Carriage of Escherichia coli from Pediatric Patients with Diarrhea and Asymptomatic Healthy Individuals.
    Saha R; Das S; De K; Singh T; Kumari A
    J Glob Infect Dis; 2014 Oct; 6(4):194-5. PubMed ID: 25538460
    [No Abstract]   [Full Text] [Related]  

  • 79. GP efforts to cut antibiotic use failed to curb spread of drug resistant E coli, evaluation finds.
    Iacobucci G
    BMJ; 2021 Aug; 374():n1953. PubMed ID: 34353814
    [No Abstract]   [Full Text] [Related]  

  • 80. Temporal Trend of ST131 Clone among Urinary
    Wang JL; Ko WC; Hung CH; Cheng MF; Wang HY; Shiau YR; Lai JF; Huang IW; Hsieh LY; Lauderdale TY; On Behalf Of Tsar Hospitals
    Microorganisms; 2021 Apr; 9(5):. PubMed ID: 33947027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.